LSNE expands lyophilization capacity at Madison, USA
This new lyophilizer is equipped with systems to best protect high value Active Pharmaceutical Ingredients (APIs) and doubles the lyophilization capacity at the site
This new lyophilizer is equipped with systems to best protect high value Active Pharmaceutical Ingredients (APIs) and doubles the lyophilization capacity at the site
The drug is being developed at lab scale for the first-line of treatment of Covid-19
According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
Extension of hypericin orphan designation beyond cutaneous T-cell lymphoma
HTL will build, validate and operate a botulinum manufacturing facility in the US
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
Subscribe To Our Newsletter & Stay Updated